オキシトシンの世界市場(2020年~2030年)

◆英語タイトル:Oxytocin Market Forecast, Trend Analysis & Opportunity Assessment 2020-2030
◆商品コード:FMI21FB033
◆発行会社(リサーチ会社):Future Market Insights
◆発行日:2020年12月23日
◆ページ数:265
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:北米、中南米、ヨーロッパ、東南アジア、オセアニア、中東・アフリカ
◆販売価格オプション(消費税別)
Individual Price(1名様閲覧用)USD5,000 ⇒換算¥570,000見積依頼/購入/質問フォーム
Corporate Price(同一法人内共有可)USD7,500 ⇒換算¥855,000見積依頼/購入/質問フォーム
Enterprise Price(複数拠点共有可)USD10,000 ⇒換算¥1,140,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はFuture Market Insights社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Future Market Insights社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

本市場調査レポートでは、世界のオキシトシン市場について調査・分析し、エグゼクティブサマリー、市場概要、主要市場動向、主要成功要因、価格分析、需要分析・予測、市場背景、新型コロナウイルス感染症の危機分析、疾患別(産前、産後)分析、流通チャネル別(病院薬局、ドラッグストア、オンライン薬局)分析、地域別分析、市場構造分析、競争分析、仮定、調査手法などを整理しました。
・エグゼクティブサマリー
・市場概要
・主要市場動向
・主要成功要因
・価格分析
・需要分析・予測
・市場背景
・新型コロナウイルス感染症の危機分析
・世界のオキシトシン市場規模:疾患別(産前、産後)
・世界のオキシトシン市場規模:流通チャネル別(病院薬局、ドラッグストア、オンライン薬局)
・世界のオキシトシン市場規模:地域別
・市場構造分析
・競争分析
・仮定
・調査手法
【レポートの概要】

A recent market study published by Future Market Insights (FMI) on the oxytocin market includes global industry analysis for 2015-2019 & opportunity assessment for 2020-2030, delivers a comprehensive assessment of the most important market dynamics. After conducting a thorough research on the historical as well as current growth parameters of the oxytocin market, growth prospects are obtained with maximum precision.

Oxytocin Market: Segmentation

The global oxytocin market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader.

Indication:
Antepartum
Postpartum

Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Drug Stores
Online Pharmacies

Region:
North America
Latin America
Europe
South Asia
East Asia
Oceania
Middle East & Africa

Report Chapters:
Chapter 01 – Executive Summary

The report initiates with the executive summary of the oxytocin market, which includes a summary of key findings and statistics of the market. It also includes market size and revenue distribution of market segment of the oxytocin market.

Chapter 02 – Market Overview

Readers can find the definition and a detailed segmentation of the oxytocin market in this chapter, which will help them understand the basic information about the market.

Chapter 03 – Key Market Trends

This chapter highlights the key trends impacting the growth of the oxytocin market over the forecast period. This chapter helps reader to understand the trends of oxytocin market.

Chapter 04 ­– Key Success Factors

This section includes key success factors such as product adoption analysis, application road map, key promotional strategies, regulations, and many more. This section helps readers understand the key factors associated with the oxytocin market.

Chapter 05 – Global Oxytocin Market: Pricing Analysis

This section highlights the global oxytocin market pricing analysis by Indication. This section helps reader to understand the pricing variation of whole slide scanner in various geography.

Chapter 06 – Global Oxytocin Market Volume (Units) Analysis 2015-2019 & Opportunity Assessment 2020-2030

This section explains the global market volume (units) analysis and forecast for the oxytocin market during the forecast period. This chapter includes a detailed analysis of the historical oxytocin market, along with an opportunity analysis of the future. Readers can also find the absolute unit opportunity for the current year (2020), and an incremental unit opportunity for the forecast period (2020–2030).

Chapter 07 – Global Oxytocin Market Value Analysis 2015-2019 & Opportunity Assessment 2020-2030

This section explains the global market value analysis and forecast for the oxytocin market during the forecast period. This chapter includes a detailed analysis of the historical oxytocin market, along with an opportunity analysis of the future. Readers can also find the absolute $ opportunity for the current year (2020), and an incremental $ opportunity for the forecast period (2020–2030).

Chapter 08 – Market Background

This chapter explains the key macroeconomic factors, drivers, restraints, and opportunity analysis that are expected to influence growth of the oxytocin market over the forecast period. Moreover, in-depth information about the market dynamics and their impact analysis on the market have been provided in the successive section.

Chapter 09 – Global Oxytocin Market: COVID19 Crisis Analysis

This section highlights COVID19 crisis analysis that are expected to influence growth of the oxytocin market over the forecast period. This section helps reader to understand the COVID19 crisis analysis in various geography.

Chapter 10 – Global Oxytocin Market Analysis 2015-2019 & Opportunity Assessment 2020-2030, by Indication

Based on indication, the oxytocin market is segmented into antepartum and postpartum. In this chapter, readers can find information about the key trends and developments in oxytocin market and market attractiveness analysis based on indication.

Chapter 11 – Global Oxytocin Market Analysis 2015-2019 & Opportunity Assessment 2020-2030, by Distribution Channel

This chapter provides details about the oxytocin market based on distribution channel, and has been classified into hospital pharmacies, drug stores, retail pharmacies and online pharmacies. In this chapter, readers can understand the market attractiveness analysis based on distribution channel.

Chapter 12 – Global Oxytocin Market Analysis 2015-2019 & Opportunity Assessment 2020-2030, by Region

This chapter explains how the oxytocin market will grow across various geographic regions such as North America, Latin America, Europe, South Asia, East Asia, Oceania, and Middle East & Africa (MEA).

Chapter 13 – North America Oxytocin Market Analysis 2015-2019 & Opportunity Assessment 2020-2030

This chapter includes a detailed analysis of growth of the North America oxytocin market, along with a country-wise assessment that includes the U.S. and Canada. Readers can also find the regional trends, and market growth based on the application and countries in North America.

Chapter 14 – Latin America Oxytocin Market Analysis 2015-2019 & Opportunity Assessment 2020-2030

This chapter provides the growth scenario of the oxytocin market in Latin American countries such as Argentina, Brazil, Mexico, and the Rest of Latin America. Along with this, assessment of the market across target segments has been provided.

Chapter 15 –Europe Oxytocin Market Analysis 2015-2019 & Opportunity Assessment 2020-2030

This chapter provides the growth scenario of the oxytocin market in Europe in several countries such as Germany, the U.K., France, Spain, Italy, Russia, and the Rest of Europe are included in this chapter.

Chapter 16 – South Asia Oxytocin Market Analysis 2015-2019 & Opportunity Assessment 2020-2030

This chapter provides the growth scenario of the oxytocin market in South Asia in several countries such as India, Thailand, Indonesia, Malaysia and Rest of South Asia are included in this chapter.

Chapter 17 – East Asia Oxytocin Market Analysis 2015-2019 & Opportunity Assessment 2020-2030

This chapter highlights the growth of the oxytocin market in East Asia by focusing on China, Japan & South Korea. This section also help readers understand the key factors that are responsible for the growth of the oxytocin market in East Asia.

Chapter 18 – Oceania Oxytocin Market Analysis 2015-2019 & Opportunity Assessment 2020-2030

This chapter highlights the growth of the oxytocin market in Oceania. This section also help readers understand the key factors that are responsible for the growth of the oxytocin market in Australia and New Zealand.

Chapter 19 – MEA Oxytocin Market Analysis 2015-2019 & Opportunity Assessment 2020-2030

This chapter provides information about how the oxytocin market will grow in major countries in the MEA region such as GCC Countries, South Africa, Egypt, Algeria, Nigeria, Morocco, Kenya, and the Rest of MEA, during the forecast period.

Chapter 20– Key and Emerging Countries Analysis

This section include deep dive analysis of oxytocin market for key and emerging countries. Reader can understand the market value by indication, distribution channel for key countries.

Chapter 21 – Market Structure Analysis

This chapter highlights the tier structure analysis, market concentration analysis and company share analysis along with sales footprint analysis of key player operating in oxytocin market.

Chapter 22 – Competition Analysis

In this chapter, readers can find a comprehensive list of all the prominent stakeholders in the oxytocin market, along with a detailed information about each company, which includes company overview, revenue shares, strategic overview, and recent company developments. Some of the market players featured in the report are Novartis AG, Pfizer Inc., Fresenius Kabi LLC, Ferring B.V., Hikma Phramaceuticals PLC, Endo International plc. (Par Sterile Products, LLC), Teva Pharmaceuticals Industries Ltd., Mylan N.V., Sun Pharmaceuticals Industries Ltd., Yuhan Corporation, and among others.

Chapter 23 – Assumptions and Acronyms

This chapter includes a list of acronyms and assumptions that provides a base to the information and statistics included in the oxytocin market report.

Chapter 24 – Research Methodology

This chapter help readers understand the research component methodology followed to obtain various conclusions as well as important qualitative and quantitative information about the oxytocin market.

Sources and Primary Research Splits (%)

Industry Interactions

Key Designations

C – Level Executives
Marketing Directors
Product Managers
Business Development Officers
Production Managers
Procurement Heads
Sales Executives
Stakeholder Category

Distributors
Traders
Raw Material Suppliers
Industry Experts
End Users
Questions

Current Market Dynamics and Challenges
Yesteryear Trends
Market Characteristics
Market Performance and Growth Quadrants
Competition Structure and Market Structure
Strategic Growth Initiatives
Near-term and Long-term Market Growth Prospects
Market Segment Splits and Authenticity
Opinions on Market Projections and Validity of Assumptions
References Catalogue

Industry Publications
World Health Organizations (WHO)
National Institute of Health (NIH)
Factiva
Company Press Releases
Annual Reports and Investor Presentations
Research Papers
Government Websites and Publications
Trade Websites

【レポートの目次】

1. Executive Summary

1.1. Global Market Outlook

1.2. Demand Side Trends

1.3. Supply Side Trends

1.4. Technology Roadmap

1.5. Analysis and Recommendations

2. Market Overview

2.1. Market Coverage / Taxonomy

2.2. Market Definition / Scope / Limitations

3. Key Market Trends

3.1. Key Trends Impacting the Market

3.2. Product Innovation / Development Trends

4. Key Success Factors

4.1. Product Adoption / Usage Analysis

4.2. Strategic Promotional Strategies

4.3. Regulatory Scenario

4.4. Disease Epidemiology

5. Global Oxytocin Market – Pricing Analysis

5.1. Regional Pricing Analysis By Indication

5.2. Pricing Break-up

5.2.1. Manufacturer Level Pricing

5.2.2. Distributor Level Pricing

5.3. Global Average Pricing Analysis Benchmark

6. Global Oxytocin Market Demand (in Volume) Analysis 2015-2019 and Forecast, 2020-2030

6.1. Historical Market Volume (Units Mn) Analysis, 2015-2019

6.2. Current and Future Market Volume (Units Mn) Projections, 2020-2030

6.2.1. Y-o-Y Growth Trend Analysis

6.2.2. Absolute Unit Opportunity Analysis

7. Global Oxytocin Market Demand (in Value or Size in US$ Mn) Analysis 2015-2019 and Forecast, 2020-2030

7.1. Historical Market Value (US$ Mn) Analysis, 2015-2019

7.2. Current and Future Market Value (US$ Mn) Projections, 2020-2030

7.2.1. Y-o-Y Growth Trend Analysis

7.2.2. Absolute $ Opportunity Analysis

8. Market Background

8.1. Macro-Economic Factors

8.1.1. Global GDP Growth Outlook

8.1.2. Global Healthcare Expenditure Outlook

8.2. Forecast Factors – Relevance & Impact

8.2.1. Increasing Prevalence of Pregnancy Complications

8.2.2. Rising number of Birth Globally

8.2.3. Growing Awareness of Induced Labor and Breastfeeding

8.3. Value Chain

8.4. Market Dynamics

8.4.1. Drivers

8.4.2. Restraints

8.4.3. Opportunity Analysis

9. COVID19 Crisis Analysis

9.1. Current COVID19 Statistics and Probable Future Impact

9.2. Current GDP Projection and Probable Impact

9.3. Current Economic Projection as compared to 2008 financial analysis

9.4. COVID19 and Impact Analysis

9.4.1. Revenue By Product

9.4.2. Revenue By Country

9.5. 2020 Market Scenario

9.6. Quarter by Quarter Forecast

9.7. Projected recovery Quarter

9.8. Recovery Scenario – Short term, Midterm and Long Term Impact

10. Global Oxytocin Market Analysis 2015-2019 and Forecast 2020-2030, by Indication

10.1. Introduction / Key Findings

10.2. Historical Market Size (US$ Mn) Analysis By Indication, 2013 – 2017

10.3. Current and Future Market Size (US$ Mn) and Forecast By Indication, 2020 – 2030

10.3.1. Antepartum

10.3.2. Postpartum

10.4. Market Attractiveness Analysis By Indication

11. Global Oxytocin Market Analysis 2015-2019 and Forecast 2020-2030, by Distribution Channel

11.1. Introduction / Key Findings

11.2. Historical Market Size (US$ Mn) Analysis by Distribution Channel, 2015 – 2019

11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Distribution Channel, 2020 – 2030

11.3.1. Hospital Pharmacies

11.3.2. Drug Stores

11.3.3. Online Pharmacies

11.4. Market Attractiveness Analysis By Distribution Channel

12. Global Oxytocin Market Analysis 2015-2019 and Forecast 2020-2030, by Region

12.1. Introduction

12.2. Historical Market Size (US$ Mn) Analysis by Region, 2015 – 2019

12.3. Current Market Size (US$ Mn) Analysis and Forecast by Region, 2020 – 2030

12.3.1. North America

12.3.2. Latin America

12.3.3. Europe

12.3.4. Middle East and Africa (MEA)

12.3.5. East Asia

12.3.6. South Asia

12.3.7. Oceania

12.4. Market Attractiveness Analysis by Region

13. North America Oxytocin Market Analysis 2015-2019 and Forecast 2020-2030

13.1. Introduction

13.2. Pricing Analysis

13.3. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2015 – 2019

13.4. Market Size (US$ Mn) Forecast by Market Taxonomy, 2020 – 2030

13.4.1. By Country

13.4.1.1. U.S.

13.4.1.2. Canada

13.4.2. By Indication

13.4.3. By Distribution Channel

13.5. Market Attractiveness Analysis

13.5.1. By Country

13.5.2. By Indication

13.5.3. By Distribution Channel

13.6. Market Trends

13.7. Key Market Participants – Intensity Mapping

13.8. Drivers and Restraints – Impact Analysis

14. Latin America Oxytocin Market 2015-2019 and Forecast 2020-2030

14.1. Introduction

14.2. Pricing Analysis

14.3. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2015 – 2019

14.4. Market Size (US$ Mn) Forecast by Market Taxonomy, 2020 – 2030

14.4.1. By Country

14.4.1.1. Brazil

14.4.1.2. Mexico

14.4.1.3. Argentina

14.4.1.4. Rest of Latin America

14.4.2. By Indication

14.4.3. By Distribution Channel

14.5. Market Attractiveness Analysis

14.5.1. By Country

14.5.2. By Indication

14.5.3. By Distribution Channel

14.6. Market Trends

14.7. Key Market Participants – Intensity Mapping

14.8. Drivers and Restraints – Impact Analysis

15. Europe Oxytocin Market 2015-2019 and Forecast 2020-2030

15.1. Introduction

15.2. Pricing Analysis

15.3. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2015 – 2019

15.4. Market Size (US$ Mn) Forecast by Market Taxonomy, 2020 – 2030

15.4.1. By Country

15.4.1.1. Germany

15.4.1.2. Italy

15.4.1.3. France

15.4.1.4. U.K.

15.4.1.5. Spain

15.4.1.6. BENELUX

15.4.1.7. Russia

15.4.1.8. Rest of Europe

15.4.2. By Indication

15.4.3. By Distribution Channel

15.5. Market Attractiveness Analysis

15.5.1. By Country

15.5.2. By Indication

15.5.3. By Distribution Channel

15.6. Market Trends

15.7. Key Market Participants – Intensity Mapping

15.8. Drivers and Restraints – Impact Analysis

16. South Asia Oxytocin Market 2015-2019 and Forecast 2020-2030

16.1. Introduction

16.2. Pricing Analysis

16.3. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2015 – 2019

16.4. Market Size (US$ Mn) Forecast by Market Taxonomy, 2020 – 2030

16.4.1. By Country

16.4.1.1. India

16.4.1.2. Thailand

16.4.1.3. Indonesia

16.4.1.4. Malaysia

16.4.1.5. Rest of South Asia

16.4.2. By Indication

16.4.3. By Distribution Channel

16.5. Market Attractiveness Analysis

16.5.1. By Country

16.5.2. By Indication

16.5.3. By Distribution Channel

16.6. Market Trends

16.7. Key Market Participants – Intensity Mapping

16.8. Drivers and Restraints – Impact Analysis

17. East Asia Oxytocin Market 2015-2019 and Forecast 2020-2030

17.1. Introduction

17.2. Pricing Analysis

17.3. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2015 – 2019

17.4. Market Size (US$ Mn) Forecast by Market Taxonomy, 2020 – 2030

17.4.1. By Country

17.4.1.1. China

17.4.1.2. Japan

17.4.1.3. South Korea

17.4.2. By Indication

17.4.3. By Distribution Channel

17.5. Market Attractiveness Analysis

17.5.1. By Country

17.5.2. By Indication

17.5.3. By Distribution Channel

17.6. Market Trends

17.7. Key Market Participants – Intensity Mapping

17.8. Drivers and Restraints – Impact Analysis

18. Oceania Oxytocin Market 2015-2019 and Forecast 2020-2030

18.1. Introduction

18.2. Pricing Analysis

18.3. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2015 – 2019

18.4. Market Size (US$ Mn) Forecast by Market Taxonomy, 2020 – 2030

18.4.1. By Country

18.4.1.1. Australia

18.4.1.2. New Zealand

18.4.2. By Indication

18.4.3. By Distribution Channel

18.5. Market Attractiveness Analysis

18.5.1. By Country

18.5.2. By Indication

18.5.3. By Distribution Channel

18.6. Market Trends

18.7. Key Market Participants – Intensity Mapping

18.8. Drivers and Restraints – Impact Analysis

19. Middle East and Africa Oxytocin Market 2015-2019 and Forecast 2020-2030

19.1. Introduction

19.2. Pricing Analysis

19.3. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2015 – 2019

19.4. Market Size (US$ Mn) Forecast by Market Taxonomy, 2020 – 2030

19.4.1. By Country

19.4.1.1. GCC Countries

19.4.1.2. South Africa

19.4.1.3. Egypt

19.4.1.4. Nigeria

19.4.1.5. Algeria

19.4.1.6. Morocco

19.4.1.7. Kenya

19.4.1.8. Rest of Middle East and Africa

19.4.2. By Indication

19.4.3. By Distribution Channel

19.5. Market Attractiveness Analysis

19.5.1. By Country

19.5.2. By Indication

19.5.3. By Distribution Channel

19.6. Market Trends

19.7. Key Market Participants – Intensity Mapping

19.8. Drivers and Restraints – Impact Analysis

20. Emerging & Key Countries Oxytocin Market Analysis

20.1. Introduction

20.1.1. Market Value Proportion Analysis, By Key Countries

20.1.2. Global Vs. Country Growth Comparison

20.2. U.S. Oxytocin Market Analysis

20.2.1. By Indication

20.2.2. By Distribution Channel

20.3. Canada Oxytocin Market Analysis

20.3.1. By Indication

20.3.2. By Distribution Channel

20.4. Mexico Oxytocin Market Analysis

20.4.1. By Indication

20.4.2. By Distribution Channel

20.5. Brazil Oxytocin Market Analysis

20.5.1. By Indication

20.5.2. By Distribution Channel

20.6. Argentina Oxytocin Market Analysis

20.6.1. By Indication

20.6.2. By Distribution Channel

20.7. Germany Oxytocin Market Analysis

20.7.1. By Indication

20.7.2. By Distribution Channel

20.8. Italy Oxytocin Market Analysis

20.8.1. By Indication

20.8.2. By Distribution Channel

20.9. France Oxytocin Market Analysis

20.9.1. By Indication

20.9.2. By Distribution Channel

20.10. U.K. Oxytocin Market Analysis

20.10.1. By Indication

20.10.2. By Distribution Channel

20.11. Spain Oxytocin Market Analysis

20.11.1. By Indication

20.11.2. By Distribution Channel

20.12. Russia Oxytocin Market Analysis

20.12.1. By Indication

20.12.2. By Distribution Channel

20.13. China Oxytocin Market Analysis

20.13.1. By Indication

20.13.2. By Distribution Channel

20.14. Japan Oxytocin Market Analysis

20.14.1. By Indication

20.14.2. By Distribution Channel

20.15. S. Korea Oxytocin Market Analysis

20.15.1. By Indication

20.15.2. By Distribution Channel

20.16. India Oxytocin Market Analysis

20.16.1. By Indication

20.16.2. By Distribution Channel

20.17. Malaysia Oxytocin Market Analysis

20.17.1. By Indication

20.17.2. By Distribution Channel

20.18. Thailand Oxytocin Market Analysis

20.18.1. By Indication

20.18.2. By Distribution Channel

20.19. Indonesia Oxytocin Market Analysis

20.19.1. By Indication

20.19.2. By Distribution Channel

20.20. Australia Oxytocin Market Analysis

20.20.1. By Indication

20.20.2. By Distribution Channel

20.21. New Zealand Oxytocin Market Analysis

20.21.1. By Indication

20.21.2. By Distribution Channel

20.22. GCC Countries Oxytocin Market Analysis

20.22.1. By Indication

20.22.2. By Distribution Channel

20.23. Turkey Oxytocin Market Analysis

20.23.1. By Indication

20.23.2. By Distribution Channel

20.24. South Africa Oxytocin Market Analysis

20.24.1. By Indication

20.24.2. By Distribution Channel

20.25. Egypt Oxytocin Market Analysis

20.25.1. By Indication

20.25.2. By Distribution Channel

20.26. Nigeria Oxytocin Market Analysis

20.26.1. By Indication

20.26.2. By Distribution Channel

20.27. Algeria Oxytocin Market Analysis

20.27.1. By Indication

20.27.2. By Distribution Channel

20.28. Morroco Oxytocin Market Analysis

20.28.1. By Indication

20.28.2. By Distribution Channel

20.29. Kenya Oxytocin Market Analysis

20.29.1. By Indication

20.29.2. By Distribution Channel

21. Market Structure Analysis

21.1. Market Analysis by Tier of Companies

21.2. Market Concentration

21.3. Market Share Analysis of Top Players

21.4. Market Presence Analysis

21.4.1. By Regional Footprint of Players

21.4.2. Product Footprint by Players

21.4.3. Channel Footprint by Players

22. Competition Analysis

22.1. Competition Dashboard

22.2. Pricing Analysis by Competition

22.3. Competition Benchmarking

22.4. Competition Deep Dive

22.5. Key Players Based On Estimated Tracked Revenue

22.5.1. Pfizer Inc.

22.5.1.1. Indication Portfolio

22.5.1.2. Profitability by Market Segments (Channel/Region)

22.5.1.3. Sales Footprint

22.5.1.4. Analyst commentary

22.5.1.5. Strategy Overview

22.5.1.5.1. Marketing Strategy

22.5.1.5.2. Product Strategy

22.5.1.5.3. Channel Strategy

22.5.2. Novartis AG

22.5.2.1. Indication Portfolio

22.5.2.2. Profitability by Market Segments (Channel/Region)

22.5.2.3. Sales Footprint

22.5.2.4. Analyst commentary

22.5.2.5. Strategy Overview

22.5.2.5.1. Marketing Strategy

22.5.2.5.2. Product Strategy

22.5.2.5.3. Channel Strategy

22.5.3. Ferring B.V.

22.5.3.1. Indication Portfolio

22.5.3.2. Profitability by Market Segments (Channel/Region)

22.5.3.3. Sales Footprint

22.5.3.4. Analyst commentary

22.5.3.5. Strategy Overview

22.5.3.5.1. Marketing Strategy

22.5.3.5.2. Product Strategy

22.5.3.5.3. Channel Strategy

22.5.4. Fresenius Kabi LLC

22.5.4.1. Indication Portfolio

22.5.4.2. Profitability by Market Segments (Channel/Region)

22.5.4.3. Sales Footprint

22.5.4.4. Analyst commentary

22.5.4.5. Strategy Overview

22.5.4.5.1. Marketing Strategy

22.5.4.5.2. Product Strategy

22.5.4.5.3. Channel Strategy

22.5.5. Hikma Pharmaceuticals PLC

22.5.5.1. Indication Portfolio

22.5.5.2. Profitability by Market Segments (Channel/Region)

22.5.5.3. Sales Footprint

22.5.5.4. Analyst commentary

22.5.5.5. Strategy Overview

22.5.5.5.1. Marketing Strategy

22.5.5.5.2. Product Strategy

22.5.5.5.3. Channel Strategy

22.5.6. Endo International plc. (Par Sterile Products, LLC)

22.5.6.1. Indication Portfolio

22.5.6.2. Profitability by Market Segments (Channel/Region)

22.5.6.3. Sales Footprint

22.5.6.4. Analyst commentary

22.5.6.5. Strategy Overview

22.5.6.5.1. Marketing Strategy

22.5.6.5.2. Product Strategy

22.5.6.5.3. Channel Strategy

22.5.7. Teva Pharmaceutical Industries Ltd.

22.5.7.1. Indication Portfolio

22.5.7.2. Profitability by Market Segments (Channel/Region)

22.5.7.3. Sales Footprint

22.5.7.4. Analyst commentary

22.5.7.5. Strategy Overview

22.5.7.5.1. Marketing Strategy

22.5.7.5.2. Product Strategy

22.5.7.5.3. Channel Strategy

22.5.8. Mylan N.V.

22.5.8.1. Indication Portfolio

22.5.8.2. Profitability by Market Segments (Channel/Region)

22.5.8.3. Sales Footprint

22.5.8.4. Analyst commentary

22.5.8.5. Strategy Overview

22.5.8.5.1. Marketing Strategy

22.5.8.5.2. Product Strategy

22.5.8.5.3. Channel Strategy

22.5.9. Wockhardt Ltd.

22.5.9.1. Indication Portfolio

22.5.9.2. Profitability by Market Segments (Channel/Region)

22.5.9.3. Sales Footprint

22.5.9.4. Analyst commentary

22.5.9.5. Strategy Overview

22.5.9.5.1. Marketing Strategy

22.5.9.5.2. Product Strategy

22.5.9.5.3. Channel Strategy

22.5.10. Sun Pharmaceutical Industries Ltd.

22.5.10.1. Indication Portfolio

22.5.10.2. Profitability by Market Segments (Channel/Region)

22.5.10.3. Sales Footprint

22.5.10.4. Analyst commentary

22.5.10.5. Strategy Overview

22.5.10.5.1. Marketing Strategy

22.5.10.5.2. Product Strategy

22.5.10.5.3. Channel Strategy

22.5.11. Yuhan Corporation

22.5.11.1. Indication Portfolio

22.5.11.2. Profitability by Market Segments (Channel/Region)

22.5.11.3. Sales Footprint

22.5.11.4. Analyst commentary

22.5.11.5. Strategy Overview

22.5.11.5.1. Marketing Strategy

22.5.11.5.2. Product Strategy

22.5.11.5.3. Channel Strategy

23. Assumptions and Acronyms Used

24. Research Methodology

Table 01: Global Oxytocin Market Volume (‘000 Units of 10 IU Doses) Analysis and Opportunity Assessment 2015–2030, By Region

Table 02: Global Oxytocin Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Indication

Table 03: Global Oxytocin Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Distribution Channel

Table 04: Global Oxytocin Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Region

Table 05: North America Oxytocin Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Country

Table 06: North America Oxytocin Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Indication

Table 07: North America Oxytocin Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Distribution Channel

Table 08: Latin America Oxytocin Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Country

Table 09: Latin America Oxytocin Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Indication

Table 10: Latin America Oxytocin Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Distribution Channel

Table 11: Europe Oxytocin Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Country

Table 12: Europe Oxytocin Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Indication

Table 13: Europe Oxytocin Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Distribution Channel

Table 14: South Asia Oxytocin Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Country

Table 15: South Asia Oxytocin Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Indication

Table 16: South Asia Oxytocin Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Distribution Channel

Table 17: East Asia Oxytocin Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Country

Table 18: East Asia Oxytocin Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Indication

Table 19: East Asia Oxytocin Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Distribution Channel

Table 20: Oceania Oxytocin Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Country

Table 21: Oceania Oxytocin Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Indication

Table 22: Oceania Oxytocin Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Distribution Channel

Table 23: Middle East and Africa Oxytocin Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Country

Table 24: Middle East and Africa Oxytocin Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Indication

Table 25: Middle East and Africa Oxytocin Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Distribution Channel

Figure 01: Oxytocin Pricing Analysis (US$) for Per 10 IU Dose, By Region, 2019

Figure 02: Global Oxytocin Market Volume (in 000' Units of 10 IU Doses) Analysis, 2015-2019

Figure 03: Global Oxytocin Market Volume Forecast (in 000' Units of 10 IU Doses), 2020-2030

Figure 04: Global Oxytocin Market Value Analysis (US$ Mn), 2015-2019

Figure 05: Global Oxytocin Market Value Forecast (US$ Mn), 2020-2030

Figure 06: Global Oxytocin Market Absolute $ Opportunity, 2020 - 2030

Figure 07: Global Oxytocin Market Share Analysis (%), By Indication, 2020-2030

Figure 08: Global Oxytocin Market Y-o-Y Analysis (%), By Indication, 2020-2030

Figure 09: Global Oxytocin Market Attractiveness Analysis By Indication, 2020-2030

Figure 10: Global Oxytocin Market Share Analysis (%), By Distribution Channel, 2020-2030

Figure 11: Global Oxytocin Market Y-o-Y Analysis (%), By Distribution Channel, 2020-2030

Figure 12: Global Oxytocin Market Attractiveness Analysis by Distribution Channel, 2020-2030

Figure 13: Global Oxytocin Market Share Analysis (%), By Region, 2020-2030

Figure 14: Global Oxytocin Market Y-o-Y Analysis (%), By Region, 2020-2030

Figure 15: Global Oxytocin Market Attractiveness Analysis by Region, 2020-2030

Figure 16: North America Oxytocin Market Value Share, By Indication, 2020 (E)

Figure 17: North America Oxytocin Market Value Share, By Distribution Channel, 2020 (E)

Figure 18: North America Oxytocin Market Value Share, By Country, 2020 (E)

Figure 19: North America Oxytocin Market Value Analysis (US$ Mn), 2015-2019

Figure 20: North America Oxytocin Market Value Forecast (US$ Mn), 2020-2030

Figure 21: North America Oxytocin Market Attractiveness Analysis by Indication, 2020-2030

Figure 22: North America Oxytocin Market Attractiveness Analysis by Distribution Channel, 2020-2030

Figure 23: North America Oxytocin Market Attractiveness Analysis by Country, 2020-2030

Figure 24: Latin America Oxytocin Market Value Share, By Indication, 2020 (E)

Figure 25: Latin America Oxytocin Market Value Share, By Distribution Channel, 2020 (E)

Figure 26: Latin America Oxytocin Market Value Share, By Country, 2020 (E)

Figure 27: Latin America Oxytocin Market Value Analysis (US$ Mn), 2015-2019

Figure 28: Latin America Oxytocin Market Value Forecast (US$ Mn), 2020-2030

Figure 29: Latin America Oxytocin Market Attractiveness Analysis by Indication, 2020-2030

Figure 30: Latin America Oxytocin Market Attractiveness Analysis by Distribution Channel, 2020-2030

Figure 31: Latin America Oxytocin Market Attractiveness Analysis by Country, 2020-2030

Figure 32: Europe Oxytocin Market Value Share, By Indication, 2020 (E)

Figure 33: Europe Oxytocin Market Value Share, By Distribution Channel, 2020 (E)

Figure 34: Europe Oxytocin Market Value Share, By Country, 2020 (E

Figure 35: Europe Oxytocin Market Value Analysis (US$ Mn), 2015-2019

Figure 36: Europe Oxytocin Market Value Forecast (US$ Mn), 2020-2030

Figure 37: Europe Oxytocin Market Attractiveness Analysis by Indication, 2020-2030

Figure 38: Europe Oxytocin Market Attractiveness Analysis by Distribution Channel, 2020-2030

Figure 39: Europe Oxytocin Market Attractiveness Analysis by Country, 2020-2030

Figure 40: South Asia Oxytocin Market Value Share, By Indication, 2020 (E)

Figure 41: South Asia Oxytocin Market Value Share, By Distribution Channel, 2020 (E)

Figure 42: South Asia Oxytocin Market Value Share, By Country, 2020 (E)

Figure 43: South Asia Oxytocin Market Value Analysis (US$ Mn), 2015-2019

Figure 44: South Asia Oxytocin Market Value Forecast (US$ Mn), 2020-2030

Figure 45: South Asia Oxytocin Market Attractiveness Analysis by Indication, 2020-2030

Figure 46: South Asia Oxytocin Market Attractiveness Analysis by Distribution Channel, 2020-2030

Figure 47: South Asia Oxytocin Market Attractiveness Analysis by Country, 2020-2030

Figure 48: East Asia Oxytocin Market Value Share, By Indication, 2020 (E)

Figure 50: East Asia Oxytocin Market Value Share, By Country, 2020 (E)

Figure 51: East Asia Oxytocin Market Value Analysis (US$ Mn), 2015-2019

Figure 52: East Asia Oxytocin Market Value Forecast (US$ Mn), 2020-2030

Figure 53: East Asia Oxytocin Market Attractiveness Analysis by Indication, 2020-2030

Figure 55: East Asia Oxytocin Market Attractiveness Analysis by Country, 2020-2030

Figure 56: Oceania Oxytocin Market Value Share, By Indication, 2020 (E)

Figure 58: Oceania Oxytocin Market Value Share, By Country, 2020 (E)

Figure 59: Oceania Oxytocin Market Value Analysis (US$ Mn), 2015-2019

Figure 60: Oceania Oxytocin Market Value Forecast (US$ Mn), 2020-2030

Figure 61: Oceania Oxytocin Market Attractiveness Analysis by Indication, 2020-2030

Figure 63: Oceania Oxytocin Market Attractiveness Analysis by Country, 2020-2030

Figure 64: Middle East and Africa Oxytocin Market Value Share, By Indication, 2020 (E)

Figure 66: Middle East and Africa Oxytocin Market Value Share, By Country, 2020 (E)

Figure 67: Middle East and Africa Oxytocin Market Value Analysis (US$ Mn), 2015-2019

Figure 68: Middle East and Africa Oxytocin Market Value Forecast (US$ Mn), 2020-2030

Figure 69: Middle East and Africa Oxytocin Market Attractiveness Analysis by Indication, 2020-2030

Figure 70: Middle East and Africa Oxytocin Market Attractiveness Analysis by Country, 2020-2030

Figure 71: U.S. Oxytocin Market Value Share, By Indication, 2020 (E)

Figure 72: U.S. Oxytocin Market Value Share, By Distribution Channel, 2020 (E)

Figure 73: U.S. Oxytocin Market Value Analysis (US$ Mn), 2020 & 2030

Figure 74: U.S Oxytocin Market Value Analysis (US$ Mn), 2015-2019

Figure 75: U.S Oxytocin Market Value Forecast (US$ Mn), 2020-2030

Figure 76: Canada Oxytocin Market Value Share, By Indication, 2020 (E)

Figure 78: Canada Oxytocin Market Value Share, By Distribution Channel, 2020 (E)

Figure 79: Canada Oxytocin Market Value Analysis (US$ Mn), 2020 & 2030

Figure 80: Canada Oxytocin Market Value Analysis (US$ Mn), 2015-2019

Figure 81: Canada Oxytocin Market Value Forecast (US$ Mn), 2020-2030

Figure 82: Mexico Oxytocin Market Value Share, By Indication, 2020 (E)

Figure 84: Mexico Oxytocin Market Value Analysis (US$ Mn), 2020 & 2030

Figure 85: Mexico Oxytocin Market Value Analysis (US$ Mn), 2015-2019

Figure 86: Mexico Oxytocin Market Value Forecast (US$ Mn), 2020-2030

Figure 87: Brazil Oxytocin Market Value Share, By Indication, 2020 (E)

Figure 89: Brazil Oxytocin Market Value Analysis (US$ Mn), 2020 & 2030

Figure 90: Brazil Oxytocin Market Value Analysis (US$ Mn), 2015-2019

Figure 91: Brazil Oxytocin Market Value Forecast (US$ Mn), 2020-2030

Figure 92: Argentina Oxytocin Market Value Share, By Indication, 2020 (E)

Figure 94: Argentina Oxytocin Market Value Analysis (US$ Mn), 2020 & 2030

Figure 95: Argentina Oxytocin Market Value Analysis (US$ Mn), 2015-2019

Figure 96: Argentina Oxytocin Market Value Forecast (US$ Mn), 2020-2030

Figure 97: Germany Oxytocin Market Value Share, By Indication, 2020 (E)

Figure 99: Germany Oxytocin Market Value Analysis (US$ Mn), 2020 & 2030

Figure 100: Germany Oxytocin Market Value Analysis (US$ Mn), 2015-2019

Figure 101: Germany Oxytocin Market Value Forecast (US$ Mn), 2020-2030

Figure 102: Italy Oxytocin Market Value Share, By Indication, 2020 (E)

Figure 104: Italy Oxytocin Market Value Analysis (US$ Mn), 2020 & 2030

Figure 105: Italy Oxytocin Market Value Analysis (US$ Mn), 2015-2019

Figure 106: Italy Oxytocin Market Value Forecast (US$ Mn), 2020-2030

Figure 107: France Oxytocin Market Value Share, By Indication, 2020 (E)

Figure 109: France Oxytocin Market Value Analysis (US$ Mn), 2020 & 2030

Figure 110: France Oxytocin Market Value Analysis (US$ Mn), 2015-2019

Figure 111: France Oxytocin Market Value Forecast (US$ Mn), 2020-2030

Figure 112: U.K. Oxytocin Market Value Share, By Indication, 2020 (E)

Figure 114: U.K. Oxytocin Market Value Analysis (US$ Mn), 2020 & 2030

Figure 115: U.K. Oxytocin Market Value Analysis (US$ Mn), 2015-2019

Figure 116: U.K. Oxytocin Market Value Forecast (US$ Mn), 2020-2030

Figure 117: Spain Oxytocin Market Value Share, By Indication, 2020 (E)

Figure 119: Spain Oxytocin Market Value Analysis (US$ Mn), 2020 & 2030

Figure 120: Spain Oxytocin Market Value Analysis (US$ Mn), 2015-2019

Figure 121: Spain Oxytocin Market Value Forecast (US$ Mn), 2020-2030

Figure 122: Russia Oxytocin Market Value Share, By Indication, 2020 (E)

Figure 124: Russia Oxytocin Market Value Analysis (US$ Mn), 2020 & 2030

Figure 125: Russia Oxytocin Market Value Analysis (US$ Mn), 2015-2019

Figure 126: Russia Oxytocin Market Value Forecast (US$ Mn), 2020-2030

Figure 127: China Oxytocin Market Value Share, By Indication, 2020 (E)

Figure 129: China Oxytocin Market Value Analysis (US$ Mn), 2020 & 2030

Figure 130: China Oxytocin Market Value Analysis (US$ Mn), 2015-2019

Figure 131: China Oxytocin Market Value Forecast (US$ Mn), 2020-2030

Figure 132: Japan Oxytocin Market Value Share, By Indication, 2020 (E)

Figure 134: Japan Oxytocin Market Value Analysis (US$ Mn), 2020 & 2030

Figure 135: Japan Oxytocin Market Value Analysis (US$ Mn), 2015-2019

Figure 136: Japan Oxytocin Market Value Forecast (US$ Mn), 2020-2030

Figure 137: South Korea Oxytocin Market Value Share, By Indication, 2020 (E)

Figure 139: South Korea Oxytocin Market Value Analysis (US$ Mn), 2020 & 2030

Figure 140: South Korea Oxytocin Market Value Analysis (US$ Mn), 2015-2019

Figure 141: South Korea Oxytocin Market Value Forecast (US$ Mn), 2020-2030

Figure 142: India Oxytocin Market Value Share, By Indication, 2020 (E)

Figure 144: India Oxytocin Market Value Analysis (US$ Mn), 2020 & 2030

Figure 145: India Oxytocin Market Value Analysis (US$ Mn), 2015-2019

Figure 146: India Oxytocin Market Value Forecast (US$ Mn), 2020-2030

Figure 147: Malaysia Oxytocin Market Value Share, By Indication, 2020 (E)

Figure 149: Malaysia Oxytocin Market Value Analysis (US$ Mn), 2020 & 2030

Figure 150: Malaysia Oxytocin Market Value Analysis (US$ Mn), 2015-2019

Figure 151: Malaysia Oxytocin Market Value Forecast (US$ Mn), 2020-2030

Figure 152: Thailand Oxytocin Market Value Share, By Indication, 2020 (E)

Figure 154: Thailand Oxytocin Market Value Analysis (US$ Mn), 2020 & 2030

Figure 155: Thailand Oxytocin Market Value Analysis (US$ Mn), 2015-2019

Figure 156: Thailand Oxytocin Market Value Forecast (US$ Mn), 2020-2030

Figure 157: Indonesia Oxytocin Market Value Share, By Indication, 2020 (E)

Figure 159: Indonesia Oxytocin Market Value Analysis (US$ Mn), 2020 & 2030

Figure 160: Indonesia Oxytocin Market Value Analysis (US$ Mn), 2015-2019

Figure 161: Indonesia Oxytocin Market Value Forecast (US$ Mn), 2020-2030

Figure 162: Australia Oxytocin Market Value Share, By Indication, 2020 (E)

Figure 164: Australia Oxytocin Market Value Analysis (US$ Mn), 2020 & 2030

Figure 165: Australia Oxytocin Market Value Analysis (US$ Mn), 2015-2019

Figure 166: Australia Oxytocin Market Value Forecast (US$ Mn), 2020-2030

Figure 167: New Zealand Oxytocin Market Value Share, By Indication, 2020 (E)

Figure 169: New Zealand Oxytocin Market Value Analysis (US$ Mn), 2020 & 2030

Figure 170: New Zealand Oxytocin Market Value Analysis (US$ Mn), 2015-2019

Figure 171: New Zealand Oxytocin Market Value Forecast (US$ Mn), 2020-2030

Figure 172: GCC Countries Oxytocin Market Value Share, By Indication, 2020 (E)

Figure 174: GCC Countries Oxytocin Market Value Analysis (US$ Mn), 2020 & 2030

Figure 175: GCC Countries Oxytocin Market Value Analysis (US$ Mn), 2015-2019

Figure 176: GCC Countries Oxytocin Market Value Forecast (US$ Mn), 2020-2030

Figure 177: Turkey Oxytocin Market Value Share, By Indication, 2020 (E)

Figure 179: Turkey Oxytocin Market Value Analysis (US$ Mn), 2020 & 2030

Figure 180: Turkey Oxytocin Market Value Analysis (US$ Mn), 2015-2019

Figure 181: Turkey Oxytocin Market Value Forecast (US$ Mn), 2020-2030

Figure 182: South Africa Oxytocin Market Value Share, By Indication, 2020 (E)

Figure 184: South Africa Oxytocin Market Value Analysis (US$ Mn), 2020 & 2030

Figure 185: South Africa Oxytocin Market Value Analysis (US$ Mn), 2015-2019

Figure 186: South Africa Oxytocin Market Value Forecast (US$ Mn), 2020-2030

Figure 187: Egypt Oxytocin Market Value Share, By Indication, 2020 (E)

Figure 189: Egypt Oxytocin Market Value Analysis (US$ Mn), 2020 & 2030

Figure 190: Egypt Oxytocin Market Value Analysis (US$ Mn), 2015-2019

Figure 191: Egypt Oxytocin Market Value Forecast (US$ Mn), 2020-2030

Figure 192: Nigeria Oxytocin Market Value Share, By Indication, 2020 (E)

Figure 194: Nigeria Oxytocin Market Value Analysis (US$ Mn), 2020 & 2030

Figure 195: Nigeria Oxytocin Market Value Analysis (US$ Mn), 2015-2019

Figure 196: Nigeria Oxytocin Market Value Forecast (US$ Mn), 2020-2030

Figure 197: Algeria Oxytocin Market Value Share, By Indication, 2020 (E)

Figure 199: Algeria Oxytocin Market Value Analysis (US$ Mn), 2020 & 2030

Figure 200: Algeria Oxytocin Market Value Analysis (US$ Mn), 2015-2019

Figure 201: Algeria Oxytocin Market Value Forecast (US$ Mn), 2020-2030

Figure 202: Morroco Oxytocin Market Value Share, By Indication, 2020 (E)

Figure 204: Morroco Oxytocin Market Value Analysis (US$ Mn), 2020 & 2030

Figure 205: Morroco Oxytocin Market Value Analysis (US$ Mn), 2015-2019

Figure 206: Morroco Oxytocin Market Value Forecast (US$ Mn), 2020-2030

Figure 207: Kenya Oxytocin Market Value Share, By Indication, 2020 (E)

Figure 209: Kenya Oxytocin Market Value Analysis (US$ Mn), 2020 & 2030

Figure 210: Kenya Oxytocin Market Value Analysis (US$ Mn), 2015-2019

Figure 211: Kenya Oxytocin Market Value Forecast (US$ Mn), 2020-2030

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[オキシトシンの世界市場(2020年~2030年)]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆